Related Experiment Video
Updated: Jan 15, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
The Silent Mimic: Actinomyces and the Enigmatic Gastric Ulcer
Annisa Zahra Mufida1, Muhammad Miftahussurur2,3
1Internal Medicine Subspeciality Study Program, Departement of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Background:
Primary gastric actinomycosis is a rare infection caused by anaerobic Actinomyces species, normally colonizing the oral and gastrointestinal flora. Often misdiagnosed as malignancy due to atypical presentation and non-specific findings, it typically affects immunocompromised individuals or those with mucosal damage from surgery or trauma.
Objective:
The aim of this case report is to explore the diagnostic challenges and the necessity of high clinical suspicion for rare infectious causes of gastrointestinal pathology, especially given its atypical presentation.
Case Presentation:
A 63-year-old woman presented with hematemesis, melena, and epigastric pain. Laboratory tests revealed severe anaemia, hypoalbuminemia, and elevated cancer antigen 19-9 (CA 19-9). Gastroscopy revealed oesophageal erosions and a gastric ulcer with a wide, black-coloured base on a polypoid lesion, along with small erosions. Histopathological findings showed filamentous and rod-like bacteria, consistent with Actinomyces, in gastroscopic biopsies. The patient was then treated with high-dose intravenous penicillin G. Conclusion: This case highlights the diagnostic challenges of gastric actinomycosis, which can be mistaken for peptic ulcers or malignancy. Clinicians should consider gastric actinomycosis, especially in immunocompromised patients, when imaging or endoscopy reveals a submucosal lesion or ulcer.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

